The Glasgow Royal Infirmary is a large teaching hospital. With a capacity of around 1,000 beds, the hospital campus covers an area of around 8 hectares, situated on the north-eastern edge of the city centre of Glasgow, Scotland. It is managed by NHS Greater Glasgow and Clyde.

There are 1,077 beds in Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary.

During the past decade, Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" #1 sponsor was "NHS Greater Glasgow and Clyde" with 3 trials, followed by "Celgene" with 2 trials sponsored, "DePuy International" with 1 trials sponsored, "Fresenius Medical Care Deutschland GmbH" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canniesburn Research Trust" with 1 trials as a collaborator, "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "NHS Lothian" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" are "Anemia" (1 trials), "Angina Pectoris" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Breast Reconstruction" (1 trials). Many other conditions were trialed in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" are "Drug" (5 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "GED-0301" (2 trials), "Placebo" (2 trials), "Air cooling to CM site" (1 trials), "Alexandrite Laser" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".